MED Quote, Financials, Valuation and Earnings

Eventiko, Inc. has a net margin of -2.53% compared to Medifast, Inc.'s net margin of --. Medifast, Inc.'s return on equity of 0.12% beat Eventiko, Inc.'s return on equity of --.

Medifast, Inc. has a consensus price target of $15.00, signalling upside risk potential of 38.25%. On the other hand Eventiko, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Medifast, Inc. has higher upside potential than Eventiko, Inc., analysts believe Medifast, Inc. is more attractive than Eventiko, Inc..

Medifast, Inc. has a beta of 0.532, which suggesting that the stock is 46.804% less volatile than S&P 500. In comparison Eventiko, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Medifast, Inc. has a quarterly dividend of $1.65 per share corresponding to a yield of 0%. Eventiko, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medifast, Inc. pays -- of its earnings as a dividend. Eventiko, Inc. pays out -- of its earnings as a dividend.

Medifast, Inc. quarterly revenues are $89.4M, which are larger than Eventiko, Inc. quarterly revenues of --. Medifast, Inc.'s net income of -$2.3M is lower than Eventiko, Inc.'s net income of -$4.3K. Notably, Medifast, Inc.'s price-to-earnings ratio is 519.14x while Eventiko, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medifast, Inc. is 0.28x versus -- for Eventiko, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Interactive Strength, Inc. has a net margin of -2.53% compared to Medifast, Inc.'s net margin of -108.64%. Medifast, Inc.'s return on equity of 0.12% beat Interactive Strength, Inc.'s return on equity of -163.73%.

Medifast, Inc. has a consensus price target of $15.00, signalling upside risk potential of 38.25%. On the other hand Interactive Strength, Inc. has an analysts' consensus of $5.13 which suggests that it could grow by 1252.24%. Given that Interactive Strength, Inc. has higher upside potential than Medifast, Inc., analysts believe Interactive Strength, Inc. is more attractive than Medifast, Inc..

Medifast, Inc. has a beta of 0.532, which suggesting that the stock is 46.804% less volatile than S&P 500. In comparison Interactive Strength, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Medifast, Inc. has a quarterly dividend of $1.65 per share corresponding to a yield of 0%. Interactive Strength, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medifast, Inc. pays -- of its earnings as a dividend. Interactive Strength, Inc. pays out -- of its earnings as a dividend.

Medifast, Inc. quarterly revenues are $89.4M, which are larger than Interactive Strength, Inc. quarterly revenues of $4.8M. Medifast, Inc.'s net income of -$2.3M is higher than Interactive Strength, Inc.'s net income of -$5.2M. Notably, Medifast, Inc.'s price-to-earnings ratio is 519.14x while Interactive Strength, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medifast, Inc. is 0.28x versus 0.03x for Interactive Strength, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Valvoline, Inc. has a net margin of -2.53% compared to Medifast, Inc.'s net margin of -6.97%. Medifast, Inc.'s return on equity of 0.12% beat Valvoline, Inc.'s return on equity of 30.84%.

Medifast, Inc. has a consensus price target of $15.00, signalling upside risk potential of 38.25%. On the other hand Valvoline, Inc. has an analysts' consensus of $41.27 which suggests that it could grow by 6.17%. Given that Medifast, Inc. has higher upside potential than Valvoline, Inc., analysts believe Medifast, Inc. is more attractive than Valvoline, Inc..

Medifast, Inc. has a beta of 0.532, which suggesting that the stock is 46.804% less volatile than S&P 500. In comparison Valvoline, Inc. has a beta of 1.194, suggesting its more volatile than the S&P 500 by 19.363%.

Medifast, Inc. has a quarterly dividend of $1.65 per share corresponding to a yield of 0%. Valvoline, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medifast, Inc. pays -- of its earnings as a dividend. Valvoline, Inc. pays out -- of its earnings as a dividend.

Medifast, Inc. quarterly revenues are $89.4M, which are smaller than Valvoline, Inc. quarterly revenues of $461.8M. Medifast, Inc.'s net income of -$2.3M is higher than Valvoline, Inc.'s net income of -$32.2M. Notably, Medifast, Inc.'s price-to-earnings ratio is 519.14x while Valvoline, Inc.'s PE ratio is 57.85x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medifast, Inc. is 0.28x versus 2.83x for Valvoline, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

WW International has a net margin of -2.53% compared to Medifast, Inc.'s net margin of -38.91%. Medifast, Inc.'s return on equity of 0.12% beat WW International's return on equity of --.

Medifast, Inc. has a consensus price target of $15.00, signalling upside risk potential of 38.25%. On the other hand WW International has an analysts' consensus of $1.10 which suggests that it could grow by 340.71%. Given that WW International has higher upside potential than Medifast, Inc., analysts believe WW International is more attractive than Medifast, Inc..

Medifast, Inc. has a beta of 0.532, which suggesting that the stock is 46.804% less volatile than S&P 500. In comparison WW International has a beta of 1.298, suggesting its more volatile than the S&P 500 by 29.755%.

Medifast, Inc. has a quarterly dividend of $1.65 per share corresponding to a yield of 0%. WW International offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medifast, Inc. pays -- of its earnings as a dividend. WW International pays out -- of its earnings as a dividend.

Medifast, Inc. quarterly revenues are $89.4M, which are smaller than WW International quarterly revenues of $186.6M. Medifast, Inc.'s net income of -$2.3M is higher than WW International's net income of -$72.6M. Notably, Medifast, Inc.'s price-to-earnings ratio is 519.14x while WW International's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medifast, Inc. is 0.28x versus 0.03x for WW International. Usually stocks with elevated PS ratios are considered overvalued.